RM-493 Treatment Trial in POMC Deficient Patients
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2017
At a glance
- Drugs Setmelanotide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 04 Nov 2016 Interim results published in the Rhythm Search Developments media release.
- 04 Nov 2016 Data from study presented at ObesityWeek 2016 conference, according to a Rhythm Search Developments media release.
- 10 Aug 2016 Planned number of patients changed from 10 to 30.